Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects

Wyeth

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: ERB-041

Study type: Interventional

Funder types: Industry

Identifiers

NCT00434187

3142A2-115

Details and patient eligibility

About

The primary objective is evaluate the safety, tolerability, and pharmacokinetics of multiple doses of ERB-041, an investigational drug, in healthy, female Japanese subjects.

Sex: Female

Ages: 20 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Healthy as determined by the investigator on the basis of medical history and screening evaluations.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind